GSE201409 coumarin Hep-G2 1 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE201409_coumarin_Hep-G2_1_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE201409_coumarin_Hep-G2_1_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE201409_coumarin_Hep-G2_1_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE201409_coumarin_Hep-G2_1_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

family with sequence similarity 66 member B

Gene

keratin 8 pseudogene 18

Gene

MAL2 antisense RNA 1

Gene

ribosomal protein SA pseudogene 14

Gene

uncharacterized LOC105373997

Gene

selenoprotein O like, pseudogene

Gene

spermatogenesis associated 2 pseudogene 1

Gene

protein kinase C eta pseudogene

Gene

uncharacterized LOC93463

Gene

HSPA5 divergent transcript

  • Gene

    family with sequence similarity 66 member B


  • Gene

    keratin 8 pseudogene 18


  • Gene

    MAL2 antisense RNA 1


  • Gene

    ribosomal protein SA pseudogene 14


  • Gene

    uncharacterized LOC105373997


  • Gene

    selenoprotein O like, pseudogene


  • Gene

    spermatogenesis associated 2 pseudogene 1


  • Gene

    protein kinase C eta pseudogene


  • Gene

    uncharacterized LOC93463


  • Gene

    HSPA5 divergent transcript

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.